Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

15
Number of overlapping holdings
19.0%
% of CNCR's 81 holdings also in IDNA
35.7%
% of IDNA's 46 holdings also in CNCR
Overlap by Weight
Sector Drift (CNCR minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in CNCR |
Weight in IDNA |
Overlap | |
---|---|---|---|---|
BLUEPRINT MEDICINES CORP. | 1.7% | 5.6% | 1.7% | |
IMMUNITYBIO INC | 2.9% | 1.4% | 1.4% | |
MACROGENICS INC | 2.0% | 1.4% | 1.4% | |
IOVANCE BIOTHERAPEUTICS INC | 1.3% | 3.0% | 1.3% | |
EXELIXIS INC | 1.2% | 5.4% | 1.2% |
Position Highlights (Non-Overlapping Exposures)
CNCR Overweight Relative to IDNA
REVOLUTION MEDICINES, INC. | 2.2% | |
MIRATI THERAPEUTICS INC | 2.2% | |
ARCELLX, INC. | 2.0% | |
AUTOLUS THERAPEUTICS PLC SPONSORED A | 2.0% | |
NUVALENT, INC. CLASS A | 1.7% | |
HUTCHISON CHINA MEDITECH LIMITED SPO | 1.6% | |
RAIN THERAPEUTICS INC | 1.6% | |
ZYMEWORKS INC. | 1.5% | |
IMMUNITYBIO INC | 1.5% | |
THESEUS PHARMACEUTICALS, INC. | 1.5% |
CNCR Underweight Relative to IDNA
CRISPR THERAPEUTICS AG | -4.6% | |
SANOFI-AVENTIS | -4.4% | |
TAKEDA PHARMACEUTICAL CO LTD | -4.2% | |
BEAM THERAPEUTICS, INC. | -4.2% | |
EXELIXIS INC | -4.2% | |
TWIST BIOSCIENCE CORP. | -4.1% | |
REGENERON PHARMACEUTICALS | -4.0% | |
ROCHE HOLDING LTD | -4.0% | |
BEIGENE, LTD. | -3.9% | |
GENMAB A/S | -3.9% |